Brain Rejuvenation by Partial Cellular Reprogramming | Yuri Deigin

แชร์
ฝัง
  • เผยแพร่เมื่อ 20 ม.ค. 2025

ความคิดเห็น • 8

  • @marquisemfj
    @marquisemfj 5 หลายเดือนก่อน +3

    We believe in you! 🙏❤

    • @YuriDeigin
      @YuriDeigin 5 หลายเดือนก่อน +3

      Thank you!

  • @InfiniteUniverse88
    @InfiniteUniverse88 4 หลายเดือนก่อน +1

    I would like to see this topic framed in terms of transcriptomics, personalized medicine, and micro-rna.

  • @greenstar2108
    @greenstar2108 4 หลายเดือนก่อน +1

    I'm not a biologist (mere mathematican) but this sounds very interesting. Presumably we would still need to deal with damage to the extracellular matrix even if it is possible to program cells to ignore dysfunctional signals from being in an old matrix, or end up suffering strokes in old age? If so, does anyone know if replacement would still ultimately end up being necessary, or would things like AGE breaking molecules be sufficient (if eventually developed) to prevent ECM degredation in the brain being eventually lethal?

    • @comradecapybara
      @comradecapybara 4 หลายเดือนก่อน +2

      I'm not a biologist either but presumably we should be able to design enzymes to breakdown any kind of undesirable proteins in the body so a live repair of the ECM may ultimately be realized from computer modeling if that continues to improve rapidly.

    • @greenstar2108
      @greenstar2108 4 หลายเดือนก่อน

      @@comradecapybara - Thanks for the reply. I will confess to not being knowlegdeable enough about computational biology to judge, but I wonder if the elastin protein still would need to be replaced, or if the cellular reprograming could be made to do the job. I guess we'll find out in the coming years.

  • @nikosalkis8296
    @nikosalkis8296 5 หลายเดือนก่อน +1

    There is one question WHEN are you going to stop tormenting animals and you start to use this knowledge on humans.

    • @YuriDeigin
      @YuriDeigin 5 หลายเดือนก่อน +7

      We’re anticipating starting a clinical trial in Alzheimer’s within 3 years if our IND-enabling studies go well